| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |